why choose us

First received: August 17, 2022

Clinical Trial: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Idiopathic Pulmonary Fibrosis

Study Type: INTERVENTIONAL


Official Title: PhIb, Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and PK of an i.v. mAb After Single Ascending Doses in Subjects Affected by Idiopathic Pulmonary Fibros

Brief Summary: The purpose of this study is to assess the safety of CHF10067 (the study drug) and any side effects that might be associated with it.In addition, the study will evaluate how much of the study drug gets into the bloodstream and how long the body takes to remove it.The body's immune response to the study drug will also be evaluated.The study may also evaluate the effect of the study drug on the level of a certain protein in the body.Chiesi is conducting this study on patients affected by idiopathic pulmonary…

Read more